Page last updated: 2024-09-03

gefitinib and tridemorph

gefitinib has been researched along with tridemorph in 1 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(tridemorph)
Trials
(tridemorph)
Recent Studies (post-2010) (tridemorph)
5,2315662,9199977301

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)tridemorph (IC50)
Cycloeucalenol cycloisomeraseZea mays0.4
Sterol-8,7-isomeraseZea mays0.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonaci, S; Azzariti, A; Fransvea, E; Giannelli, G; Paradiso, A; Porcelli, L1

Other Studies

1 other study(ies) available for gefitinib and tridemorph

ArticleYear
Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cells.
    British journal of cancer, 2004, Nov-29, Volume: 91, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Adhesion Molecules; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Kalinin; Phosphorylation; Predictive Value of Tests; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinazolines

2004